adcendo
Manufacturing · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Copenhagen, Capital Region, DenmarkWebsite
www.adcendo.dkRevenue
<$5 MillionIndustry
About adcendo
Is adcendo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if adcendo is spiking on competitors!
Product Launch: Get notified when adcendo launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at adcendo
Funding: Get notified immidiatlly once adcendo has new funding data
Click to see if adcendo had a recent Job posting/layoffs
Earning: See what the market has to say on adcendo recently announced quarterly report
adcendo, which may be a good buyer, showed buying intent in Masked Content Topic
Check if adcendo has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at adcendo
Find 2 more new buyers
Company Profile Activity
Activity Insights
adcendo is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
adcendo is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about adcendo.
adcendo financials insights
Gather financial insights about adcendo, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$62M
adcendo Tech Stack
A closer look at the technologies used by adcendo
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding adcendo
Adcendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. The company focuses on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.... Read More